4//SEC Filing
Riley Jeffrey Scott 4
Accession 0001493152-24-012340
CIK 0001819411other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 4:01 PM ET
Size
5.1 KB
Accession
0001493152-24-012340
Insider Transaction Report
Form 4
Riley Jeffrey Scott
Director
Transactions
- Purchase
Common Stock
2024-03-28$3.86/sh+30,000$115,770→ 30,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.7098 to $3.924, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
Gain Therapeutics, Inc.
CIK 0001819411
Entity typeother
Related Parties
1- filerCIK 0001487645
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 4:01 PM ET
- Size
- 5.1 KB